Long intergenic non-protein coding RNA 662 accelerates the progression of gastric cancer through up-regulating centrosomal protein 55 by sponging microRNA-195-5p

被引:14
作者
Tao, Fei [1 ]
Qi, Likun [2 ]
Liu, Guoqing [1 ]
机构
[1] Qinghai Prov Peoples Hosp, Dept Oncol, Xining, Peoples R China
[2] Fifth Peoples Hosp, Dept Gastrointestinal Surg, Xining, Peoples R China
关键词
Gastric cancer; LINC00662; miR-195-5p; CEP55; SIGNALING PATHWAY; CEP55; MIRNA; PROLIFERATION; INHIBITION; APOPTOSIS; MIDBODY; GROWTH;
D O I
10.1080/21655979.2021.2023978
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Long non-coding RNAs (lncRNAs) are important players in regulating diverse human diseases, including cancers. Nonetheless, the function of long intergenic non-protein coding RNA 662 (LINC00662) in gastric cancer (GC) carcinogenesis and progression remains to be delineated. In the present study, LINC00662, microRNA-195-5p (miR-195-5p) and centrosomal protein 55 (CEP55) mRNA expression levels were quantified by qRT-PCR. GC cell proliferation, migration and invasion were analyzed by CCK-8, BrdU and Transwell assays. Besides, dual-luciferase reporter and RNA pull-down assays were conducted for verifying the targeting relationships of LINC00662, miR-195-5p and CEP55. The regulatory functions of LINC00662 and miR-195-5p on CEP55 were examined utilizing Western blot. In this study, it was revealed that LINC00662 expression level was elevated in GC tissues and cells. LINC00662 overexpression facilitated the malignant biological behaviors of GC cells whereas knockdown of LINC00662 worked oppositely. In terms of mechanism, LINC00662 targeted miR-195-5p to modulate CEP55 expression. In conclusion, LINC00662 facilitates the malignant biological behaviors of GC cells via miR-195-5p/CEP55 axis, and therefore, it may be a promising target for GC treatment.
引用
收藏
页码:3007 / 3018
页数:12
相关论文
共 38 条
[1]   Changing Trends in Stomach Cancer Throughout the World [J].
Balakrishnan M. ;
George R. ;
Sharma A. ;
Graham D.Y. .
Current Gastroenterology Reports, 2017, 19 (8)
[2]   LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer [J].
Cao, Xianxiang ;
Xu, Jing ;
Yue, Dong .
CANCER GENE THERAPY, 2018, 25 (1-2) :10-17
[3]   CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway [J].
Chen, H. ;
Zhu, D. ;
Zheng, Z. ;
Cai, Y. ;
Chen, Z. ;
Xie, W. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (07) :939-949
[4]   Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis [J].
Fabbro, M ;
Zhou, BB ;
Takahashi, M ;
Sarcevic, B ;
Lal, P ;
Graham, ME ;
Gabrielli, BG ;
Robinson, PJ ;
Nigg, EA ;
Ono, Y ;
Khanna, KK .
DEVELOPMENTAL CELL, 2005, 9 (04) :477-488
[5]   Long noncoding RNAs in innate and adaptive immunity [J].
Fitzgerald, Katherine A. ;
Caffrey, Daniel R. .
CURRENT OPINION IN IMMUNOLOGY, 2014, 26 :140-146
[6]   Long non-coding RNA Linc00662 promotes cell invasion and contributes to cancer stem cell-like phenotypes in lung cancer cells [J].
Gong, Wenjing ;
Su, Yi ;
Liu, Yan ;
Sun, Ping ;
Wang, Xiumei .
JOURNAL OF BIOCHEMISTRY, 2018, 164 (06) :461-469
[7]   An overview of microRNAs [J].
Hammond, Scott M. .
ADVANCED DRUG DELIVERY REVIEWS, 2015, 87 :3-14
[8]   Overcoming sternness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling [J].
Jin, Yinghu ;
Wang, Meng ;
Hu, Hanging ;
Huang, Quanlong ;
Chen, Yinggang ;
Wang, Guiyu .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 117 :445-453
[9]   CEP55 promotes cell proliferation and inhibits apoptosis via the PI3K/Akt/p21 signaling pathway in human glioma U251 cells [J].
Li, Feng ;
Jin, Dan ;
Tang, Chuanxi ;
Gao, Dianshuai .
ONCOLOGY LETTERS, 2018, 15 (04) :4789-4796
[10]   LncRNA SNHG1 Regulates the Progression of Esophageal Squamous Cell Cancer by the miR-204/HOXC8 Axis [J].
Li, Hao Miao ;
Yu, Yong Kui ;
Liu, Qi ;
Wei, Xiu Feng ;
Zhang, Jun ;
Zhang, Rui Xiang ;
Sun, Hai Bo ;
Wang, Zong Fei ;
Xing, Wen Qun ;
Li, Yin .
ONCOTARGETS AND THERAPY, 2020, 13 :757-767